{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:27:22Z","timestamp":1791358042162,"version":"4.3.1"},"reference-count":59,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100000888","name":"W. M. Keck Foundation","doi-asserted-by":"publisher","award":["995699 | MR | 9181"],"award-info":[{"award-number":["995699 | MR | 9181"]}],"id":[{"id":"10.13039\/100000888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>There is currently a revolution in the pharmacologic treatment of obesity and diabetes with newly available agonists of incretin receptors. The health benefits of these novel treatments include not only metabolic effects but also improvements in brain neurodegenerative conditions. Receptors for incretins have been described in the hypothalamic appetite regulatory center; however, their expression in the peripheral nervous system (PNS) has been largely overlooked, despite likely contributing important effects. For example, the PNS is essential for the control of numerous metabolically relevant pathways in tissues such as liver, adipose, intestine, and muscle, and incretin receptors are found on nerves innervating some, if not all, of these metabolically important tissues. In this article, we summarize the knowledge to date regarding incretin receptors and incretin drug actions in the PNS, as well as PNS control over incretin release, and the related implications for metabolic disease states that are accompanied by peripheral neuropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>The peripheral nervous system controls gut glucagon-like peptide 1 (GLP-1) release through enteric and sympathetic neurons. Sensory, motor, and enteric neurons express GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, and vagal neurons express the GLP-1 receptor only. GLP-1 and GIP receptors are expressed in both murine and human adipose tissue nerves and Schwann cells. Available data indicate incretin drugs are a promising novel treatment for peripheral nerve diseases. The differential pharmacodynamic properties of incretin drugs should be explored further in the prevention and treatment of metabolic disease\u2013associated peripheral nerve degeneration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db25-0158","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T19:01:58Z","timestamp":1753124518000},"page":"1313-1319","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":12,"title":["Incretin Receptors in the Peripheral Nervous System: Implications for Obesity Treatment and Peripheral Neuropathy"],"prefix":"10.2337","volume":"74","author":[{"given":"Erica","family":"de Sousa","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, College of Medicine, The Ohio State University 1 , Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sparks","sequence":"additional","affiliation":[{"name":"Translational Research Institute, AdventHealth 2 , Orlando, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2849-9195","authenticated-orcid":false,"given":"Kristy","family":"Townsend","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, College of Medicine, The Ohio State University 1 , Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"2026061114073495700_B1","doi-asserted-by":"crossref","first-page":"109952","DOI":"10.1016\/j.neuropharm.2024.109952","article-title":"Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson\u2019s and Alzheimer\u2019s disease clinical trials: a revolution in the making?","volume":"253","author":"H\u00f6lscher","year":"2024","journal-title":"Neuropharmacology"},{"key":"2026061114073495700_B2","doi-asserted-by":"crossref","first-page":"bqae167","DOI":"10.1210\/endocr\/bqae167","article-title":"GLP-1 and the neurobiology of eating control: recent advances","volume":"166","author":"Jones","year":"2025","journal-title":"Endocrinology"},{"key":"2026061114073495700_B3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1566-0702(02)00182-0","article-title":"Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons","volume":"102","author":"Kakei","year":"2002","journal-title":"Auton Neurosci"},{"key":"2026061114073495700_B4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autneu.2003.11.001","article-title":"Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells","volume":"110","author":"Nakagawa","year":"2004","journal-title":"Auton Neurosci"},{"key":"2026061114073495700_B5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/db15-0973","article-title":"Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia","volume":"65","author":"Krieger","year":"2016","journal-title":"Diabetes"},{"key":"2026061114073495700_B6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.cmet.2021.05.002","article-title":"Gut-brain communication by distinct sensory neurons differently controls feeding and glucose metabolism","volume":"33","author":"Borgmann","year":"2021","journal-title":"Cell Metab"},{"key":"2026061114073495700_B7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.molmet.2018.03.016","article-title":"Profiling of G protein-coupled receptors in vagal afferents reveals novel gut-to-brain sensing mechanisms","volume":"12","author":"Egerod","year":"2018","journal-title":"Mol Metab"},{"key":"2026061114073495700_B8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2017.03.019","article-title":"Activation of Wnt signaling increases numbers of enteric neurons derived from neonatal mouse and human progenitor cells","volume":"153","author":"Zhang","year":"2017","journal-title":"Gastroenterology"},{"key":"2026061114073495700_B9","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.4507-11.2012","article-title":"Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility","volume":"32","author":"Vianna","year":"2012","journal-title":"J Neurosci"},{"key":"2026061114073495700_B10","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.celrep.2019.05.055","article-title":"Distinct neural sites of GLP-1R expression mediate physiological versus pharmacological control of incretin action","volume":"27","author":"Varin","year":"2019","journal-title":"Cell Rep"},{"key":"2026061114073495700_B11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1463-1326.2011.01431.x","article-title":"GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice","volume":"13","author":"Jolivalt","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"2026061114073495700_B12","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2337\/db10-1462","article-title":"Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice","volume":"60","author":"Himeno","year":"2011","journal-title":"Diabetes"},{"key":"2026061114073495700_B13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/NEN.0b013e3182580673","article-title":"Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy","volume":"71","author":"Kan","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026061114073495700_B14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/biom12101338","article-title":"Liraglutide attenuates glucolipotoxicity-induced RSC96 Schwann cells\u2019 inflammation and dysfunction","volume":"12","author":"Kornelius","year":"2022","journal-title":"Biomolecules"},{"key":"2026061114073495700_B15","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/en.2006-0153","article-title":"Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats","volume":"148","author":"Vahl","year":"2007","journal-title":"Endocrinology"},{"key":"2026061114073495700_B16","doi-asserted-by":"crossref","first-page":"e0198024","DOI":"10.1371\/journal.pone.0198024","article-title":"Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons","volume":"13","author":"Anand","year":"2018","journal-title":"PLoS One"},{"key":"2026061114073495700_B17","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"2026061114073495700_B18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/jpet.300.3.958","article-title":"A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells","volume":"300","author":"Perry","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"2026061114073495700_B19","first-page":"348","article-title":"The neurotrophic function of glucagon-like peptide-1 promotes human neuroblastoma differentiation via the PI3K-AKT axis","volume":"9","author":"Yang","year":"2020","journal-title":"Biology (Basel)"},{"key":"2026061114073495700_B20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jdi.12129","article-title":"Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice","volume":"5","author":"Okawa","year":"2014","journal-title":"J Diabetes Investig"},{"key":"2026061114073495700_B21","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/jnr.22001","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth","volume":"87","author":"Buhren","year":"2009","journal-title":"J Neurosci Res"},{"key":"2026061114073495700_B22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jnc.15816","article-title":"The activation of gastric inhibitory peptide\/gastric inhibitory peptide receptor axis via sonic hedgehog signaling promotes the bridging of gapped nerves in sciatic nerve injury","volume":"165","author":"Guan","year":"2023","journal-title":"J Neurochem"},{"key":"2026061114073495700_B23","doi-asserted-by":"crossref","first-page":"G23","DOI":"10.1152\/ajpgi.00189.2019","article-title":"Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves","volume":"319","author":"Mayer","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026061114073495700_B24","doi-asserted-by":"crossref","first-page":"e0221766","DOI":"10.1371\/journal.pone.0221766","article-title":"Neuropathy and neural plasticity in the subcutaneous white adipose depot","volume":"14","author":"Blaszkiewicz","year":"2019","journal-title":"PLoS One"},{"key":"2026061114073495700_B25","doi-asserted-by":"crossref","first-page":"106189","DOI":"10.1016\/j.isci.2023.106189","article-title":"Schwann cells contribute to demyelinating diabetic neuropathy and nerve terminal structures in white adipose tissue","volume":"26","author":"Willows","year":"2023","journal-title":"iScience"},{"key":"2026061114073495700_B26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41586-020-2527-y","article-title":"A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue","volume":"583","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"2026061114073495700_B27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41586-024-07863-6","article-title":"Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat","volume":"634","author":"Zhu","year":"2024","journal-title":"Nature"},{"key":"2026061114073495700_B28","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1210\/endo.135.6.7988423","article-title":"Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon","volume":"135","author":"Plaisancie","year":"1994","journal-title":"Endocrinology"},{"key":"2026061114073495700_B29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0196-9781(00)00167-4","article-title":"Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum","volume":"21","author":"Herrmann-Rinke","year":"2000","journal-title":"Peptides"},{"key":"2026061114073495700_B30","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1210\/en.2003-0143","article-title":"Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells","volume":"144","author":"Anini","year":"2003","journal-title":"Endocrinology"},{"key":"2026061114073495700_B31","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/endo.143.6.8840","article-title":"Muscarinic receptors control postprandial release of glucagon-like peptide-1: in\u00a0vivo and in\u00a0vitro studies in rats","volume":"143","author":"Anini","year":"2002","journal-title":"Endocrinology"},{"key":"2026061114073495700_B32","first-page":"786","article-title":"Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors","volume":"82","author":"Balks","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061114073495700_B33","doi-asserted-by":"crossref","first-page":"E939","DOI":"10.1152\/ajpendo.00197.2004","article-title":"Neural regulation of glucagon-like peptide-1 secretion in pigs","volume":"287","author":"Hansen","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026061114073495700_B34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2016.01.003","article-title":"Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1","volume":"773","author":"Nilsson","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"2026061114073495700_B35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.neuron.2023.12.012","article-title":"Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, brain glucose utilization, and cognitive function","volume":"112","author":"Ren","year":"2024","journal-title":"Neuron"},{"key":"2026061114073495700_B36","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat Med"},{"key":"2026061114073495700_B37","doi-asserted-by":"crossref","first-page":"1385463","DOI":"10.3389\/fendo.2024.1385463","article-title":"Case report: nerve fiber regeneration in children with melanocortin 4 receptor gene mutation related obesity treated with semaglutide","volume":"15","author":"Gad","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026061114073495700_B38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.sla.0000183349.16877.84","article-title":"Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters","volume":"243","author":"Le Roux","year":"2006","journal-title":"Ann Surg"},{"key":"2026061114073495700_B39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11695-021-05869-x","article-title":"Long-term weight outcome after bariatric surgery in patients with melanocortin-4 receptor gene variants: a case-control study of 105 patients","volume":"32","author":"Cooiman","year":"2022","journal-title":"Obes Surg"},{"key":"2026061114073495700_B40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/cimb46010021","article-title":"The effect of liraglutide on axon regeneration and functional recovery after peripheral nerve lesion","volume":"46","author":"Yal\u00e7\u0131n","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"2026061114073495700_B41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/1735-3327.316652","article-title":"Efficacy of exenatide, ozone, and methyl prednisolone for the recovery of infraorbital nerve paresthesia after injury in rats","volume":"18","author":"Abrishami","year":"2021","journal-title":"Dent Res J (Isfahan)"},{"key":"2026061114073495700_B42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4103\/1673-5374.205105","article-title":"Exenatide promotes regeneration of injured rat sciatic nerve","volume":"12","author":"Kuyucu","year":"2017","journal-title":"Neural Regen Res"},{"key":"2026061114073495700_B43","doi-asserted-by":"crossref","first-page":"315848","DOI":"10.1155\/2013\/315848","article-title":"Therapeutic effect of exendin-4, a long-acting analogue of glucagon-like peptide-1 receptor agonist, on nerve regeneration after the crush nerve injury","volume":"2013","author":"Yamamoto","year":"2013","journal-title":"Biomed Res Int"},{"key":"2026061114073495700_B44","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1476-5381.2011.01272.x","article-title":"Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats","volume":"164","author":"Liu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"2026061114073495700_B45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy","volume":"203","author":"Perry","year":"2007","journal-title":"Exp Neurol"},{"key":"2026061114073495700_B46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/awu307","article-title":"Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes","volume":"138","author":"Gibbons","year":"2015","journal-title":"Brain"},{"key":"2026061114073495700_B47","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/01.WNL.0000142038.43946.06","article-title":"A controlled study of peripheral neuropathy after bariatric surgery","volume":"63","author":"Thaisetthawatkul","year":"2004","journal-title":"Neurology"},{"key":"2026061114073495700_B48","doi-asserted-by":"crossref","first-page":"23247096241264635","DOI":"10.1177\/23247096241264635","article-title":"The tirzepatide drop: beware of slimmer\u2019s paralysis","volume":"12","author":"Tucker","year":"2024","journal-title":"J Investig Med High Impact Case Rep"},{"key":"2026061114073495700_B49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamaophthalmol.2024.6058","article-title":"Ophthalmic complications associated with the antidiabetic drugs semaglutide and tirzepatide","volume":"143","author":"Katz","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"2026061114073495700_B50","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"2026061114073495700_B51","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1177\/19322968241268050","article-title":"Real-world evidence assessment of the risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"18","author":"Klonoff","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"2026061114073495700_B52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clnesp.2022.03.009","article-title":"Prevalence of low skeletal muscle mass following bariatric surgery","volume":"49","author":"Molero","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"2026061114073495700_B53","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2337\/dci23-0100","article-title":"Incretin-based weight loss pharmacotherapy: can resistance exercise optimize changes in body composition?","volume":"47","author":"Locatelli","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061114073495700_B54","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.ijo.0803483","article-title":"Changes in fat-free mass during significant weight loss: a systematic review","volume":"31","author":"Chaston","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"2026061114073495700_B55","doi-asserted-by":"crossref","first-page":"1428835","DOI":"10.3389\/fendo.2024.1428835","article-title":"Causality between sarcopenia and diabetic neuropathy","volume":"15","author":"Fang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026061114073495700_B56","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.clinph.2021.05.033","article-title":"Effect of exenatide on peripheral nerve excitability in type 2 diabetes","volume":"132","author":"Issar","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"2026061114073495700_B57","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1592\/phco.29.11.1280","article-title":"A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus","volume":"29","author":"Sullivan","year":"2009","journal-title":"Pharmacotherapy"},{"key":"2026061114073495700_B58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00125-023-06072-6","article-title":"Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy","volume":"67","author":"Dhanapalaratnam","year":"2024","journal-title":"Diabetologia"},{"key":"2026061114073495700_B59","unstructured":"Ara\n              B\n            , DunlapS, RussellJ. Impact of tirzepatide, a GLP1\/GIP receptor agonist, on the relative risk of developing diabetic neuropathy in patients with type 2 diabetes mellitus. Presented at the 2024 Peripheral Nerve Society Annual Meeting, 22\u201325 June 2024, at the Palais des Congr\u00e8s de Montr\u00e9al, Montreal, Quebec, Canada"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/74\/8\/1313\/836676\/db250158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/74\/8\/1313\/836676\/db250158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:07:47Z","timestamp":1781201267000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/74\/8\/1313\/158251\/Incretin-Receptors-in-the-Peripheral-Nervous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,7,21]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db25-0158","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}